- Home
- CRBU vs TNYA Comparison
CRBU vs TNYA Comparison
Compare CRBU & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRBU | TNYA |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 204.8M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRBU | TNYA |
|---|---|---|
| Price | $1.79 | $1.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $9.33 | $8.60 |
| AVG Volume (30 Days) | ★ 5.0M | 2.7M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,295,000.00 | N/A |
| Revenue This Year | $8.06 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $0.36 |
| 52 Week High | $3.54 | $4.01 |
Technical Indicators
Market Signals| Indicator | CRBU | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 37.01 | 44.75 |
| Support Level | $1.72 | $1.18 |
| Resistance Level | $1.97 | $1.43 |
| Average True Range (ATR) | 0.15 | 0.11 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 11.21 | 31.71 |
Price Performance
Historical ComparisonAbout CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.